USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Purac Biochem BV

USPTO PatentsView assignee record - 121 granted patents across 57 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

121

Total patents granted

CPC technology areas

16.7

Avg claims per patent

-2%

5-year filing velocity

The verdict

Purac holds 121 US patents across 57 technology areas, rank #3,123 of 50,000 tracked assignees.

#3,123
of 50,000 US assignees by volume: Top 6%
by Innovation Score (55.9/100): 16.7
avg claims per patent: -2%
filing velocity, last 5 yrs

Portfolio overview

Purac Biochem BV has been granted 121 US utility patents between 2015 and 2025, placing Purac Biochem BV at rank #3,123 across all assignees tracked by PlainPatent. This portfolio spans 57 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.7 claims per patent with primary concentration in C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE). As a Foreign Corporation, Purac Biochem BV is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Purac sits between Glaxosmithkline Llc (121 patents, rank #3,119) and Shutterfly, Llc (121 patents, rank #3,127) - the closest US assignees by grant volume. The composite Innovation Score of 55.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 60 grants, compared with 61 in the 2015–2019 window, a -2% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Purac Biochem BV's 16.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 57 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Purac Biochem BV against peers pursuing similar technology classes.

Glaxosmithkline

121
Hefei BOE Display…

121
Institute of Auto…

121
Landscape Forms

121
Shinkawa

121
Sunrise Memory

121
Shukla Medical

121
Shutterfly

121
Purac Biochem BV ◀

121

What this shows Purac holds 121 patents at rank #3,123, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Purac

By rank, the assignees closest to #3,123 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Purac's primary technology class.

Purac's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

56 Top 6% higher than 94% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Purac Biochem BV patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	5.0%
2016	9	7.4%
2017	13	10.7%
2018	21	17.4%
2019	12	9.9%
2020	19	15.7%
2021	11	9.1%
2022	13	10.7%
2023	4	3.3%
2024	10	8.3%
2025	3	2.5%

Which technologies does Purac Biochem BV patent most?

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 46

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 37

A23B - PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES 16

A23V - INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION 16

C01F - COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS 16

C01B - NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; ; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C 15

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 13

C07D - HETEROCYCLIC COMPOUNDS 13

C08G - MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS 13

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 13

B01D - SEPARATION 9

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 9

C07K - PEPTIDES 8

C09J - ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES 7

Y02E - REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION 7

Top 15 of 57 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#3,123

Across all tracked assignees

Innovation Score

55.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Purac Biochem BV hold?

Purac Biochem BV holds 121 US granted patents filed between 2015 and 2025, spanning 57 technology areas.

What is Purac Biochem BV's Innovation Score?

Purac Biochem BV has an Innovation Score of 55.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Purac Biochem BV focus on?

Purac Biochem BV's top technology area is C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE) with 46 patents. The company has filed patents in 57 CPC subclasses total.

Is Purac Biochem BV's patent filing rate increasing or decreasing?

Purac Biochem BV's recent filing velocity is -2% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Purac Biochem BV's patents?

Purac Biochem BV's patents average 16.7 claims each. This falls within the standard range, providing solid legal coverage.

How is the Purac Biochem BV patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Purac's 121 grants land it in the top 6% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Purac ranks #3,123 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12P - see who else leads that technology area. C12P leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.